Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
2013 · Journal of Translational Medicine · 59 citations
https://doi.org/10.1186/1479-5876-11-204
X
Xiaoxiao Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
434
Citations
11
h-index
12
i10-index
Xiaoxiao Li is an academic researcher from Binzhou Medical University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & FOXO transcription factor regulation & Cancer Mechanisms and Therapy. The author has an h-index of 11, co-authored 24 publications.
ORCID: 0000-0001-7001-3227Papers by this author
worksHER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma
2021 · Journal of Cancer Research and Clinical Oncology · 14 citations
https://doi.org/10.1007/s00432-021-03522-9
Overexpression of Her-2 upregulates FoxM1 in gastric cancer
2014 · International Journal of Molecular Medicine · 9 citations
https://doi.org/10.3892/ijmm.2014.1732
Clinical significance and positive correlation of FoxM1 and Her-2 expression in gastric cancer
2013 · Clinical and Experimental Medicine · 7 citations
https://doi.org/10.1007/s10238-013-0261-6
Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study
2024 · Frontiers in Oncology · 6 citations
https://doi.org/10.3389/fonc.2024.1464735
A novel approach for engineering DHCM/GelMA microgels: application in hepatocellular carcinoma cell encapsulation and chemoresistance research
2025 · Frontiers in Bioengineering and Biotechnology · 5 citations
https://doi.org/10.3389/fbioe.2025.1564543
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat